Search results
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 12 hours agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 6 hours agoSunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 6 hours agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 4 days ago(Photo Illustration by Jakub Porzycki/NurPhoto/Getty Images) Since last week, hundreds of social...
From In-House at AstraZeneca to an E-discovery Startup: New Fileread GC Discusses Major Career Move...
Law.com· 7 hours agoThe fast evolution of artificial intelligence is spurring a new generation of legal tech...
AstraZeneca's Covid-19 vaccine linked to fatal blood clotting disorder?
MSN News· 4 days agoThe PF4 antibodies in the classical adenoviral vector VITT and the adenovirus infection-associated...
AstraZeneca Plans $1.5 Billion Manufacturing Facility In Singapore
The Wall Street Journal· 20 hours agoThe Anglo-Swedish pharmaceutical giant plans to build a $1.5 billion manufacturing facility in...
AstraZeneca to build $1.5bn ADCs facility in Singapore
Investment Monitor via Yahoo Finance· 17 hours agoPharmaceutical giant AstraZeneca has announced plans to invest $1.5bn in a new antibody-drug...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 18 hours agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Earnings call: Compugen outlines progress and plans in Q1 2024 earnings By Investing.com
Investing.com· 4 hours agoThe company highlighted its successful transition of AI-predicted drug targets to clinical trials...